You are viewing an incomplete version of our website. Please click to reload the website as full version.

ICP36 DNA Binding Protein (CMV ICP36) antibody

Details for Product No. ABIN265543, Supplier: Login to see
Antigen
Reactivity
Cytomegalovirus (CMV)
1
Host
Mouse
1
Clonality (Clone)
Monoclonal ()
Application
Immunofluorescence (IF), ELISA, Western Blotting (WB)
1
1
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Clone 10D8
Isotype IgG1 kappa
Purification Affinity Purified
Purity > 95 % IgG by SDS-PAGE
Background Synonyms: pUL44, MDBP, pp52, DB52
Research Area Virology
Application Notes Western Blotting: > 1:80.000. Immunofluorescence: 1+ at 1:12.800. ELISA: 0.100 at 1:102.400
Restrictions For Research Use only
Concentration 1.0 mg/ml
Buffer Phosphate Buffered Saline pH 7.4 (no azide)
Preservative Azide free
Supplier Images
Immunofluorescence (IF) image for anti-ICP36 DNA Binding Protein (CMV ICP36) antibody (ABIN265543) Immunofluorescence
Western Blotting (WB) image for anti-ICP36 DNA Binding Protein (CMV ICP36) antibody (ABIN265543) Western Blotting
 image for anti-ICP36 DNA Binding Protein (CMV ICP36) antibody (ABIN265543) Cross reactivity results
Product cited in: Ponroy, Taveira, Mueller et al.: "Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains." in: Journal of medical virology, 2014 (PubMed).

Qin, Penkert, Kalejta: "Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency." in: Journal of virology, 2013 (PubMed).

Albright, Kalejta: "Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations." in: Journal of virology, 2013 (PubMed).

Gudleski-ORegan, Greco, Cristea et al.: "Increased Expression of LDL Receptor-Related Protein 1 during Human Cytomegalovirus Infection Reduces Virion Cholesterol and Infectivity." in: Cell host & microbe, Vol. 12, Issue 1, pp. 86-96, 2012 (PubMed).

Strang, Boulant, Kirchhausen et al.: "Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments." in: mBio, Vol. 3, Issue 1, 2012 (PubMed). (1:100).

Hakki, Drummond, Houser et al.: "Resistance to maribavir is associated with the exclusion of pUL27 from nucleoli during human cytomegalovirus infection." in: Antiviral research, Vol. 92, Issue 2, pp. 313-8, 2011 (PubMed).

Hwang, Saffert, Kalejta: "Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication." in: mBio, Vol. 2, Issue 2, pp. e00023-11, 2011 (PubMed).

Perng, Qian, Fehr et al.: "The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts." in: Journal of virology, Vol. 85, Issue 10, pp. 4841-52, 2011 (PubMed).

Kim, Kim, Huh et al.: "Role of non-covalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth." in: Journal of virology, 2010 (PubMed).